Get the Stockscreener App
1.86
1.64%
0.03
Qualigen Therapeutics Inc stock is traded at $1.86, with a volume of 15,069.
It is up +1.64% in the last 24 hours and down -38.00% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$1.83
Open:
$1.84
24h Volume:
15,069
Relative Volume:
0.02
Market Cap:
$3.04M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-0.6992
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-2.11%
1M Performance:
-38.00%
6M Performance:
-47.57%
1Y Performance:
-82.26%
1-Day Range:
$1.8201
$1.88
1-Week Range:
$1.82
$2.09
52-Week Range:
$1.61
$10.50
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
1.86 | 3.11M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
What MACD signals say about Qualigen Therapeutics Inc.Market Growth Report & Real-Time Volume Analysis - Newser
Qualigen Therapeutics Inc. Bounces Off Moving Average SupportPortfolio Return Report & Verified Momentum Stock Ideas - classian.co.kr
Historical volatility pattern of Qualigen Therapeutics Inc. visualizedJuly 2025 Rallies & Stepwise Trade Signal Implementation - Newser
Will breakout in Qualigen Therapeutics Inc. lead to full recoveryPortfolio Return Summary & Detailed Earnings Play Alerts - Newser
Sector ETF performance correlation with Qualigen Therapeutics Inc.July 2025 Trends & Safe Entry Zone Tips - Newser
Volume spikes in Qualigen Therapeutics Inc. stock – what they meanJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Intraday pattern recognizer results for Qualigen Therapeutics Inc.Weekly Gains Report & Low Risk Entry Point Tips - Newser
Will Qualigen Therapeutics Inc. benefit from sector rotationWeekly Investment Report & Real-Time Stock Price Movement Reports - newsyoung.net
Will Qualigen Therapeutics Inc. continue its uptrendEarnings Summary Report & Weekly Market Pulse Updates - Newser
Chart Patterns Forming a Bullish Setup in Qualigen Therapeutics Inc.GDP Growth & Free Weekly Chart Analysis and Trade Guides - metal.it
Full technical analysis of Qualigen Therapeutics Inc. stockQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
Does Qualigen Therapeutics Inc. fit your quant trading model2025 Short Interest & Daily Risk Controlled Trade Plans - Newser
Qualigen Therapeutics, Inc. SEC 10-Q Report - TradingView
Using data filters to optimize entry into Qualigen Therapeutics Inc.Chart Signals & Long-Term Investment Growth Plans - Newser
Chart based analysis of Qualigen Therapeutics Inc. trendsRate Cut & Low Risk Growth Stock Ideas - Newser
Comparing Qualigen Therapeutics Inc. in custom built stock radarsEarnings Growth Report & Risk Managed Investment Entry Signals - Newser
What makes Qualigen Therapeutics Inc. stock price move sharplyEarnings Growth Report & High Return Stock Watch Alerts - Newser
Technical signs of recovery in Qualigen Therapeutics Inc.Weekly Investment Recap & Advanced Technical Signal Analysis - Newser
Should you wait for a breakout in Qualigen Therapeutics Inc.Daily Market Momentum Summary and Strategy - Newser
Statistical indicators supporting Qualigen Therapeutics Inc.’s strengthSwing Entry Risk Mitigation with Chart Analysis - Newser
Is Qualigen Therapeutics Inc. forming a bottoming baseBuy Signal Forecast With Short-Term Data - Newser
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):